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Objective: To observe the therapeutic effect of antihyperlipidemic decoction on hyperlipemia. Methods: 77 
hyperlipemia patients are selected and randomly divided into two groups. 37 cases in the treatment group 
received the treatment of antihyperlipidemic decoction, and 40 cases in the control group received western 
medicine, zhinbiticose. The course of treatment for both groups was 8 weeks. Results: The difference in total 
effective rate between the two groups was significant (P<0.05). Conclusion: Antihyperlipidemic decoction 
has a better therapeutic effect for hyperlipemia, with a lower recurrence rate and less side effect.  
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The authors have treated 77 cases of hyperlipemia by 
antihyperlipidemic decoction (a self-prescribed 
formula for clearing blood-lipid by resolving phlegm 
and eliminating dampness, and activating blood and 
dispelling stasis) with a satisfactory result as reported 
in the following. 
CLINICAL MATERIALS 
All the patients were outpatients from the authors’ 
hospital. According to the chapter of hyperlipemia in 
Practical Internal Medicine and the guiding principle 
on treatment of hyperlipemia in Guidelines of 
Clinical Research on New Drugs of Traditional 
Chinese Medicines,
1
 the inclusive criteria were 
formulated: 1) blood lipid level were measured for 
two times within two weeks under regular diet, TC 
≥5.72 mmol/L or TG ≥1.70 mmol/L, or male: HDL-C 
≤1.04 mmol/L, female: HDL-C ≤1.17 mmol/L. 2) 
being up to diagnostic criteria of phlegm-damp and 
blood stasis syndrome in TCM: the main symptoms 
being dizziness or distention of the head, headache or 
numbness of extremities, accompanied by lumbar 
soreness and weakness, fatigue; thoracic oppression, 
shortness of breath; distending pain in the chest and 
hypochondrium, precordial stabbing pain; obesity, 
abdominal distention, poor appetite, etc; pale and 
enlarged tongue or tongue with petechiae, and 
soft-slippery pulse or wiry-slippery pulse. 
All the patients who fitted in with the criteria of 
laboratory findings and had above two items of the 
main symptoms of TCM as well as one group of 
accompanied symptoms could be included. All the 
patients with nephritic syndrome, hypothyroidism, 
diabetes and secondary hyperlipemia due to other 
diseases were excluded from this series. 
All the 77 cases were randomly divided into two 
groups. Of them, 37 cases were in the treatment 
group and 40 cases in the control group. There were 
no significant differences in sex, age, duration of 
illness, BMI, the blood-lipid level before treatment 
(Table 1). 
Table 1. General data 
Groups n Sex (M/F) Age Duration of illness (year) Body Weight (kg) 
Treatment group 37 17/20 58.54±10.77 6.20±5.00 25.63±5.00 
Control group 40 20/20 61.27±8.93 4.30±7.79 24.85±3.61 
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METHODS 
Antihyperlipidemic decoction was used in the 
treatment group. Sheng Pu Huang (生蒲黄 Pollen 
Typhae), Sheng Yi Yi Ren (生薏苡仁 Semen Coicis), 
Sheng Shan Zha (生山楂 Fructus Crataegi), Jue Ming 
Zi (决明子 Semen Cassias), Ze Xie (泽泻 Rhizoma 
Alismatis), Dan Shen ( 丹 参 Radix Salviae 
Miltiorrhizae) and Huang Qi (黄芪 Radix Astragali) 
were decocted in water. The decoction was orally 
administered to the patients in the treatment group 
one dose per day in equally divided portions (150 ml 
each time twice daily). Zhinbiticose was orally 
administered to the patients in the control group, 
1.05g each time, three times daily. 8-week was one 
therapeutic course for the two groups. The patients 
were advised to keep the usual pattern of daily life 
and routine food habits and withhold any drug which 
might affect the blood lipid metabolism. 
Observation methods 
Blood samples were intravenously drawn in the 
fasting state to measure TC, TG, LDL-C, Apo-B, 
HDL-c and Apo-A before treatment and 8 weeks after 
treatment with Olympus auto-biochemical analyzer. 
The results of laboratory findings were expressed as 
mmol/L. Body mass index (BMI) was measured at 
the same time. 
The functions of the liver and kidney, routine tests of 
blood and urine and ECG were examined before and 
after treatment for the two groups. 
The above indices were re-checked to observe the 
recurrence rate after withdrawing drug for 3 months. 
Therapeutic criteria 
The therapeutic standards for hyperlipemia in 
Guidelines of Clinical Research on New Drugs of 
Traditional Chinese Medicines were adopted in 
evaluation of the therapeutic effects. Markedly 
improved: the changes in blood lipids reached any 
item of the followings, TC decreased by ≥20%, TG 
decreased by ≥40%, HDL-C increased by ≥0.26 
mmol/L, and TC-HDL-C/HDL-C decreased by ≥20%; 
Improved: the changes in blood lipids reached any 
item of the followings, TC decreased by ≥10% but 
<20%, TG decreased by ≥20% but <40%, increasing 
of HDL-C increased by ≥0.104 mmol/L but <0.26 
mmol/L; Failed: the changes in blood lipids did not 
reach the above criteria.  
Side-effect 
The side-effect was observed and recorded during the 
administration of the drugs in the two groups. 
Statistic methods 
The data were analyzed statistically with SPSS 
statistic software. 
RESULTS 
The total effective rate in the treatment group was 
much better than that in the control group after 
8-week treatment (Table 2). In the treatment group, 
TC, TG, LDL-C and BMI were significantly 
decreased (P<0.01) after treatment as compared to 
those before treatment, and the decrements of TC, TG 
in the treatment group were significantly higher than 
those in the control group (P<0.01). In the control 
group, LDL-C and BMI were significantly decreased 
(P<0.01) after treatment, but insignificant differences 
in TC and TG before and after treatment were seen 
(Table 3).  
The recurrence rate in the treatment group was much 
lower than that in the control group after withdrawing 
the drug for three months (Table 4). No obvious side- 
effect was found during administration of the drugs in 
the two groups.  
Table 2. Comparison of the clinical therapeutic effects between the two groups [n (%)] 
Groups n Markedly improved Improved Failed Total effective rate 
Treatment group 37 16 19 2 94.6% 
Control group 40 12 20 8 80.0% 
Note: Intergroup comparison, P<0.05 
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Table 3. Comparison of the change of the blood lipid indices between the two groups ( x ±s) 
Treatment group Control group 
Items 
Pre-treatment Post-treatment Pre-treatment Post-treatment 
TC(mmol/L) 6.14±1.06 5.55±0.81** 6.10±0.84 5.92±0.71 
TG (mmol/L) 2.72±1.37 2.08±1.21** 2.29±0.91 2.37±0.98 
HDL-C(mmol/L) 1.02±0.33 1.31±0.96 1.23±0.35 1.48±0.92 
LDL-C(mmol/L) 4.57±1.37 3.73±1.07** 4.07±1.04   3.53±0.96** 
ApoA(g/L) 1.14±0.33 1.15±0.17 1.17±0.22 1.16±0.14 
ApoB(g/L) 1.22±0.78 1.14±0.37 1.10±0.31  1.22±0.40* 
BMI 25.63±3.08 24.29±2.26** 24.85±3.61  24.27±2.97** 
Note: *P<0.05 improved; **P<0.01 remarkably improved.  
Table 4. Comparison of recurrence between the two groups 
Groups n Recurrence No-recurrence Recurrence rate (%) 
Treatment group 37 4 33 10.8 
Control group 40 10 30 40 
Note: Intergroup comparison, P<0.01 
DISCUSSION 
Hyperlipemia is closely related with “phlegm” in 
traditional Chinese medicine. Phlegm is divided into 
internal and external phlegm. External phlegm is 
caused by over intake of fat and sweet food, 
producing dampness and phlegm while internal 
phlegm is caused by dysfunction of zang-fu organs, 
especially dysfunction of the spleen, resulting in 
disorder of transportation and transformation of water 
and food. When the functions of the zang-fu organs 
are affected, food overtaken or water can not be 
normally transported and transformed, leading to 
retention, and turning the retention into turbidity, fat 
into phlegm-damp, affecting the blood vessels, 
resulting in obstructed circulation of qi and blood, 
thus phlegm combined with blood stasis remain 
inside the vessels, which further injures the functions 
of the zang-fu organs, giving rise to the occurrence of 
this disease. Therefore, as the pathological products 
and pathogenic factors, phlegm and blood stasis are 
the key factors for the onset of hyperlipemia. 
Through clinical observation and lab research, 
modern experts think TC, TG, and LDL-C are the 
main features and biochemical material basis of 
hyperlipemia caused by phlegm. The objective 
property of the blood stasis is manifested by the 
abnormal changes of hemodynamics, micro- 
circulation dysfunction and abnormal hemorheology.
3
 
So it is widely acknowledgeable that phlegm 
turbidity with stagnant blood is the main 
pathogenesis, which provides the objective basis for 
the treatment of hyperlipemia. Sheng Pu Huang (生
蒲黄 Pollen Typhae), Sheng Shan Zha (生山楂
Fructus Crataegi) and Dan Shen (丹参 Radix Salviae 
Miltiorrhizae) have the functions of activating blood 
and resolving stasis to expel phlegm in the vessels; 
Ze Xie (泽泻 Rhizoma Alismatis) and Sheng Yi Yi 
Ren (生薏苡仁 Semen Coicis) can strengthen the 
spleen and remove dampness; Jue Ming Zi (决明子
Semen Cassias) clears heat and removes turbidity; 
Sheng Huang Qi (黄芪 Radix Astragali) that acts on 
the lung and spleen channels, combines with Sheng 
Pu Huang (生蒲黄 Pollen Typhae), Sheng Shan Zha 
(生山楂 Fructus Crataegi) and Dan Shen (丹参 Radix 
Salviae Miltiorrhizae), which may tonify qi to 
promote blood circulation, strengthen the function of 
activating blood and removing blood stasis. The 
formula may resolve phlegm and remove blood stasis, 
turbidity and lipid, and treat the symptoms as well as 
the root cause of the disease. Researches indicate that 
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Huang Qi (黄芪 Radix Astragali ) has the function of 
adjusting blood-lipid of the mice and improve the 
ability of antioxidation.
4
 Pu Huang (蒲黄 Pollen 
Typhae) was applied to feed the quails with 
hyperlipemia through the stomach and the level of 
TC and TG greatly decreased.
5
 Jue Ming Zi (决明子
Semen Cassias) may significantly increase the 
content of HDL-C, improve the ratio of HDL-C and 
TC and improve TC distribution inside the body.
6
 
Clinical researches indicate that therapeutic effect of 
antihyperlipidemic decoction on hyperlipemia of 
phlegm-turbidity and blood stasis is reliable and 
satisfactory, with no side-effect and low recurrence 
rate. Further research is expected to be carried out. 
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